Background and Purpose-Little is known about the acute precipitants of ischemic stroke, although evidence suggests infections contribute to risk. We hypothesized that acute hospitalization for infection is associated with the short-term risk of stroke. Methods-The case-crossover design was used to compare hospitalization for infection during case periods (90, 30, or 14 days before an incident ischemic stroke) and control periods (equivalent time periods exactly 1 or 2 years before stroke) in the Cardiovascular Health Study, a population-based cohort of 5888 elderly participants from 4 US sites. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated by conditional logistic regression. Confirmatory analyses assessed hazard ratios of stroke from Cox regression models, with hospitalization for infection as a time-varying exposure. Results-During a median follow-up of 12.2 years, 669 incident ischemic strokes were observed in participants without a baseline history of stroke. Hospitalization for infection was more likely during case than control time periods; for 90 days before stroke, ORϭ3.4 (95% CI, 1.8 to 6.5). The point estimates of risks were higher when we examined shorter intervals: for 30 days, ORϭ7.3 (95% CI, 1.9 to 40.9), and for 14 days, ORϭ8.0 (95% CI, 1.7 to 77.3). In survival analyses, risk of stroke was associated with hospitalization for infection in the preceding 90 days, adjusted hazard ratioϭ2.4 (95% CI, 1.6 to 3.4). Conclusions-Hospitalization for infection is associated with a short-term increased risk of stroke, with higher risks observed for shorter intervals preceding stroke. (Stroke. 2011;42:00-00.)
K nowledge of acute stroke precipitants is primitive. Identification of particular time periods during which stroke risk is elevated could prove a valuable strategy to reduce stroke incidence through the introduction of appropriate prevention strategies during a period of vulnerability. Studies of acute precipitants lend themselves to different methodologies than do studies of chronic risk factors. In an analysis of the acute precipitants of stroke, for example, intraindividual differences may be more important than between-person differences. The factor of interest is not the characteristic making 1 person more likely than another to have a stroke, but rather what makes 1 individual more likely to have stroke at a particular point in time.
The case-crossover design is particularly suited to assessing potential precipitants. 1 Case-crossover analyses are based on data about relatively short intervals of time leading to events, contrasted with data from comparable periods of time in the same individual. Events that occur more frequently just before stroke than at other time intervals are more likely to be precipitants. Each participant thus serves as his own control, and the analysis implicitly accounts for most interindividual differences. The case-crossover design has been used only sparingly to identify triggers of stroke 2 compared with myocardial infarction. [3] [4] [5] We hypothesized that the risk of ischemic stroke would be higher during the 90 days after hospitalization for infection compared with the same period of time 1 and 2 years before stroke. The Cardiovascular Health Study (CHS) is a multicenter, prospective study of vascular risk factors in an elderly population-based cohort. CHS afforded the opportunity to address our hypothesis with a case-crossover design and to seek confirmation with survival analyses.
Methods
Details of the CHS have been described elsewhere. 6 -8 In brief, a random sample of men and women age Ն65 years (nϭ5888) was recruited from Medicare eligibility lists in 4 US communities. The institutional review board at each site approved the study methods, and all participants gave written, informed consent.
The CHS Cerebrovascular Adjudication Committee adjudicated all suspected events according to standard criteria. 9 Strokes were classified as ischemic or hemorrhagic according to all available information from informant interviews, medical records, and brain imaging studies. These analyses are limited to incident ischemic strokes not related to a procedure.
We used a case-crossover design in which participants served as their own controls. Exposure was defined as hospitalization for infection within 90, 30, or 14 days before stroke (case period) or equivalent time periods exactly 1 or 2 years before the stroke (control periods). In a few participants, control periods occurred before study enrollment and were coded as missing. Hospitalization for infection was based on hospital discharge ICD-9 codes (see the Appendix in the online-only Data Supplement). Primary central nervous system infections and endocarditis were excluded because of their known potential to directly cause stroke. Up to 10 codes were abstracted per hospitalization. Codes in any position were counted. Hospitalizations that occurred Յ4 days before stroke were not treated as exposures to avoid including hospitalizations for the stroke itself, in which infections may have been diagnosed secondarily. When the relation of infection to the originally recorded stroke date was unclear, medical charts were reviewed to determine the temporal relation of stroke and infection. The first day of hospitalization was considered the first day of infection. For participants with Ͼ1 hospitalization for infection, each hospitalization within a case or control period was considered an exposure.
The prevalence of exposure during these time intervals was compared with the prevalence of exposure during the same calendar period 1 and 2 years before the event (see the Figure) . Confounding by age is possible, because as participants age, their risk of stroke and hospitalization for infection increase. To reduce potential confounding, only time periods Յ2 years before the stroke were included. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). For analyses with Ͻ5 periods per cell, we used exact conditional logistic regression. The null hypothesis was that the prevalence of exposure would remain constant across all time intervals.
To confirm our case-crossover findings, we also fit a Cox proportional-hazards model among participants without a baseline history of stroke, by using the same ICD-9 codes for hospitalization with infection, and incident ischemic stroke as the outcome. These analyses allowed adjustment for factors (such as age) that change over time and may confound the case-crossover findings. Hospitalization for infection was treated as a time-varying exposure in the Cox model; participants were nonexposed until hospitalization; remained exposed for 14-, 30-, or 90-day intervals; and then became nonexposed until their next eligible hospitalization. Hospitalizations for infection occurring after stroke were not included in the analyses. Participants were followed up for events from 1989 through June 2005. Censoring occurred on the date of death, loss to follow-up, study dropout, or nonischemic stroke. Strokes occurring within 4 days after the hospital admission date were not counted; participants were censored at that date. Analyses were adjusted for baseline age, sex, race, diabetes mellitus (defined as self-reported use of insulin or oral hypoglycemic agents or having a fasting glucose value Ն126 mg/dL), and current smoking, due to known associations with infections and stroke risk. We tested for interactions between hospitalized infection and diabetes and, as a measure of underlying atherosclerosis, carotid artery intima-media thickness (cIMT, as a continuous variable) to assess effect modification. Maximum common and internal cIMTs were measured at baseline. 10 Nonnormally distributed measurements were logarithmically transformed. Analyses were performed with STATA, version 10.1 (Stata Corp, College Station, TX).
Results

Description of the Cohort and Hospitalizations for Infections
During a median 12.2 years of follow-up, 5639 CHS participants without a baseline history of stroke experienced 669 incident, nonprocedure-related ischemic strokes. Baseline characteristics are provided in Table 1 . Of these 669 participants, 29 had at least 1 hospitalization for infection during the preceding 90 days. Types and frequencies of infections are shown in the online-only Table ( http://stroke.ahajournals.org).
Case-Crossover Analyses
Among 669 stroke cases, 8 individuals were hospitalized for infection during the 4 to 14 days before the stroke, whereas only 2 stroke cases had hospitalizations in the same 10-day Figure. Illustration of the case-crossover design. The figure shows an example timeline illustrating case and control time periods for a hypothetical participant who enrolled in the study in January 1990 and had a stroke on December 30, 2004 . The case period represents the 90 days before the stroke, excluding the 4 days immediately preceding the stroke, as infections during those dates were considered to possibly be secondary to stroke rather than preceding it. Control periods represent the same calendar periods 1 and 2 years before the stroke. More remote time periods were not included, as their inclusion could add to bias owing to participant aging in the case-crossover analyses, because participants serve as their own controls. Analyses then compared the prevalence of hospitalization for infection between case and both control time periods considered together. Analyses were repeated for 30-and 14-day time windows.
calendar periods 1 and 2 years prior ( Table 2) . Hospitalization for infection within 14 days was associated with an increased risk of stroke (ORϭ8.0; 95% CI, 1.6 to 77.3; Pϭ0.007). The elevated risk persisted for each predefined time window, with a decreasing point estimate for magnitude of risk as the time interval lengthened ( Table 2 ). The risk of stroke after hospitalization for infection within the previous 90 days remained elevated (ORϭ3.4; 95% CI, 1.8 to 6.5).
Survival Analyses
The incidence of first ischemic stroke was 11.0 per 1000 person-years in the 5639 CHS participants without a baseline history of stroke (Table 1) . Of 2387 participants hospitalized for infection, 29 (1.2%) had a stroke within 90 days of the hospitalization. Most infections were classified as miscellaneous (ICD-9 codes 1 to 134), respiratory (acute respiratory infections, influenza, and pneumonia), and involving the urinary tract.
After adjusting for age, sex, and race, hospitalization for infection was associated with an increased risk of ischemic stroke in the following 30 days (hazard ratioϭ2.5; 95% CI, 1.4 to 4.6). The results remained essentially unchanged after additionally adjusting for diabetes and smoking (hazard ratioϭ2.5; 95% CI, 1.4 to 4.5). Further adjusting for cIMT did not appreciably attenuate the findings (Table 3) . Hospitalization for infection during the 14-day time window was associated with a higher point estimate for risk of stroke than was hospitalization during the 30-and 90-day time windows. The association between hospitalization for infection and risk of stroke was modified by internal cIMT in the 90-day (Pϭ0.04), 30-day (Pϭ0.05), and 14-day (Pϭ0.01) windows, such that the risk of stroke associated with hospitalization decreased with increasing IMT. We found similar interactions with common cIMT. We found no significant interactions with diabetes.
Discussion
We found complementary evidence from case-crossover and survival analyses of an association between hospitalization for infection and stroke risk. A graded, temporal association was evident, such that the risk of stroke was highest within 14 days after hospitalization for infection, with a decreasing but still elevated risk during the subsequent 90 days. The effect was attenuated in survival analyses in which hospitalization for infection was treated as a time-varying exposure, but it remained significant. Many infections in the cohort were either respiratory or involved the urinary tract. These findings support hypotheses that stroke is not merely a stochastic event but is associated with particular triggers, that acute infection is 1 trigger, and that the risk of stroke may vary by time since infection. [11] [12] [13] Moreover, we found no evidence of an effect modification by diabetes, although diabetes was a significant covariate in all models. We also found consistent evidence that the association between hospitalization for infection and risk of stroke is modified by cIMT, a subclinical measure of atherosclerosis, although our finding that hospitalization for infection is less strongly associated with incident stroke in the presence of increased carotid IMT may be counterintuitive. Our initial hypothesis was that the risk would be greater among those with preexisting vascular disease. Those with less atherosclerosis, however, may be at higher risk than those with more advanced disease, in whom an acute trigger carries less weight than their intrinsic disease. This finding is consistent with analyses of chronic inflammation as a risk 
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factor for stroke or atherosclerosis, whereby the effect of inflammation is greater among those with fewer atherosclerotic risk factors. 14 A case-control analysis of recent respiratory infection as a trigger for stroke similarly provided evidence that the effect of infections was attenuated among those at higher underlying risk. 15 Previous case-control studies have reported that recent infection (for example, within 1 week), primarily upper respiratory infection, is associated with stroke. 16 -21 Such studies are limited, however, by potential confounding owing to underlying risk factors, such as smoking, that could lead to both infection and stroke. In a prospective analysis of Ͼ50 000 stroke patients with the case-series method, both recent upper respiratory and urinary tract infections were associated with an increased risk of stroke. 22 The risk of stroke in the 3 days after infection was Ϸ3 times as high as during infection-free periods and gradually diminished during the following 3 months. Our results are consistent with those findings and extend them to incident strokes among a biracial group of elderly US residents.
Specific viral infections, such as influenza, have been associated with an increased short-term stroke risk. Casecontrol studies provide evidence that influenza vaccination is associated with a 50% reduction in risk of stroke. 23 Pilot clinical trials in patients with coronary disease also suggest that vaccination reduces cardiovascular risk. 24 Recent guidelines recommend annual flu vaccination for cardiovascular patients to prevent not only flu but also cardiovascular disease. 25 Further indirect evidence that acute infection precipitates stroke is available from studies of leukocyte count and stroke risk. In the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events trial, for instance, patients were monitored for neutropenia, and increases in leukocyte count were associated with a short-term increased stroke risk. 26 Among 211 patients who had an ischemic stroke during follow-up, leukocyte levels in the prior week, but not earlier, were significantly increased above baseline (mean difference, ϩ5ϫ10 8 cells/L).
Several direct biologic mechanisms could account for the increased risk of stroke associated with infections. Severe infections are associated with hypercoagulability and platelet activation that contribute to tissue ischemia and necrosis of many organs during sepsis. 27, 28 Even subseptic infections increase platelet reactivity and platelet-leukocyte interactions, leading to an increased risk of platelet aggregation, potentially precipitating stroke. Platelet activation assessed by P-selectin expression, and platelet-leukocyte aggregates, were both increased in stroke patients compared with controls. 29 These effects are even greater among stroke patients with a history of infection within 1 week before stroke. Organisms implicated in causing atherosclerosis and ischemic events have also been associated with platelet aggregation, including Chlamydia pneumoniae, Helicobacter pylori, and periodontal infections. 30 -32 Infections may also impair endothelial function. Leukocyte count has been related to reduced endothelial reactivity in cross-sectional studies. 33 Acute upper respiratory infections may also transiently impair endothelium-dependent relaxation in children. 34 Among 135 children with acute infection, brachial artery flow-mediated dilation was reduced compared with children 2 weeks out from infection and control children. Brachial artery reactivity of the acutely infected children returned to normal by 1 year later.
More general reasons may also explain why patients hospitalized for infection have stroke. Patients with acute infections may become dehydrated, either because of fever and increased insensible fluid losses, or because of decreased appetite and thirst. Pulmonary infections may increase the chance for cardiac dysfunction and atrial arrhythmias that could lead to embolism. More severely infected patients may become immobilized when hospitalized, increasing the risk for deep venous thrombosis and paradoxical embolism. Data allowing us to classify the specific etiologic subtypes of ischemic stroke were limited. Also, factors that influence admission, rather than infection itself, may be related to the risk of stroke. Patients who are frail or have comorbidities may be more likely to be hospitalized for infection than are healthier patients. Our study has limitations. The number of participants in the time-interval groups was small, and thus, our findings should be interpreted with caution. We relied on hospital discharge codes to identify infections. Thus, our findings cannot be generalized to nonhospitalized infections. We also did not have data on whether patients discontinued use of stroke-protective medications, such as antiplatelet agents, when hospitalized. In addition, our case-crossover analyses may be confounded by participant aging, because both the risk of stroke and hospitalization increase with age. 35 We limited this bias by analyzing only the 2 years before stroke, rather than more remote time intervals, and by using a confirmatory study design less susceptible to this bias. We also cannot exclude the possibility that hospitalization itself or factors associated with hospitalization, rather than infection per se, are responsible for the association with stroke. Our study cannot establish causality.
Strengths of our study include its well-characterized cohort with a long follow-up and the large number of incident ischemic stroke events. Events were adjudicated by a group of specialists in cerebrovascular disease, and hospital discharge summaries were available in all cases.
The identification of a short-term state of elevated stroke risk after infection could have therapeutic implications. For example, the period during and soon after hospitalization for infection could constitute a "treatable moment," during which patients could be evaluated for cardiovascular risk and standard preventive strategies could be instituted, including antiplatelet agents and statins. Although we were unable to confirm an effect modification by diabetes but did identify a potential effect modification by atherosclerotic burden, additional studies are needed to determine which patients with acute infection may be at greatest risk. Among those at high risk, there may be a role for increased doses of antiplatelet agents or statins during times of fever or infection, although this approach would require testing in a clinical trial. Alternatively, therapies directed at preventing infectious stressors could be targeted to stroke patients. Currently, guidelines for influenza vaccine 36 include patients Ͼ50 and debilitated stroke patients at increased risk of respiratory complications. Our results, as well as other recent evidence, [23] [24] [25] suggest that prevention of influenza in high-risk patients may prevent not only influenza but also stroke. 
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